0 published articles · Updated continuously
20 trials tracked for Respiratory Insufficiency: 3 in phase 3 or 4 and 2 with published results. The most-cited published study has 63 citations.
Showing the 20 most-cited and recently-updated of 20 trials. Browse the full registry →
Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.
Astral was shown to significantly improve clinical markers by reducing the Oxygen Desaturation Index 4% (ODI4%) from 7.61 to 3.16 (p=0.0134) 3.
The administration of Sugammadex did not result in a statistically significant increase in breathing due to a reduction in inspired oxygen saturation (Hypoxic Ventilatory Response) 1.
AI synthesis of 3 cited trials, updated Aug 21, 2026. Informational only — not medical advice; trial data sourced from ClinicalTrials.gov. How we use AI.